Market Tracker

08/18 5:16pm ET

Depomed Inc (NASDAQ:DEPO)

6.55
Delayed Data
As of 3:59pm ET
 +0.25 / +3.97%
Today’s Change
5.88
Today|||52-Week Range
27.02
-63.65%
Year-to-Date

Today’s Trading

Previous close6.30
Today’s open6.21
Day’s range6.16 - 6.63
Volume1,240,773
Average volume (3 months)1,724,753
Market cap$396.8M
Dividend yield--
Data as of 3:59pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)-15.08%
Earnings growth (this year)-28.60%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+33.02%
P/E ratioNM
Price/Sales2.42
Price/Book1.56

Competitors

 Today’s
change
Today’s
% change
PGNXProgenics Pharmaceut...-0.10-1.76%
SVASinovac Biotech Ltd+0.02+0.30%
KPTIKaryopharm Therapeut...+0.06+0.74%
SNNASienna Biopharmaceut...+0.33+1.73%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting dateNovember 6, 2017
EPS forecast (this quarter)$0.12
Annual revenue (last year)$455.9M
Annual profit (last year)-$88.7M
Net profit margin-19.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Arthur Joseph Higgins
Chief Financial Officer &
Senior Vice President
August J. Moretti
Corporate headquarters
Newark, California

Forecasts